C Reactive Protein (CRP) Testing Market - Forecasts From 2018 to 2023

November 2018 | 110 pages | ID: CFA9F764165EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global C Reactive Protein (CRP) testing market is projected to grow at a CAGR of 2.34%, increasing from US$1.743 billion in 2017 to US$2.002 billion in 2023. C-reactive protein (CRP) is produced in the liver and is a major blood test market for inflammation in the body. The level of the CRP rise in response to the inflammation in the body. CRP is typically not detected in the blood unless some degree of inflammation is present in the body. C-reactive protein testing is done to check for flare-ups of inflammatory diseases such as rheumatoid arthritis, lupus, or vasculitis, predictor of cardiovascular risk or to monitor whether anti-inflammatory medications are working to treat a disease or condition. High R&D in the field of C-reactive protein (CRP) testing coupled with the favourable government policies are expected to drive the market during the given forecast period. However, high Cost of the CRP testing instruments might restrain the market during the given time frame. Lack of skilled professional in the field will also hamper the market for CRP testing during the given time period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global C reactive protein (CRP) testing market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global C reactive protein (CRP) testing market.

Major industry players profiled as part of the report are Siemens Healthcare Private Limited, Abbott and Salimetrics, LLC among others.

Segmentation

By Type
Immunoturbidimetric method
ELISA
Chemiluminescence
Spectrometry
By Application
Cardiovascular diseases
Cancer
Rheumatoid Arthritis
Lupus
Others
By End Users
Hospitals and Clinics
Diagnostic Centres
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. GLOBAL C REACTIVE PROTEIN (CRP) TESTING MARKET FORECAST BY TYPE

5.1. Immunoturbidimetric method
5.2. ELISA
5.3. Chemiluminescence
5.4. Spectrometry

6. GLOBAL C REACTIVE PROTEIN (CRP) TESTING MARKET FORECAST BY APPLICATION

6.1. Cardiovascular diseases
6.2. Cancer
6.3. Rheumatoid Arthritis
6.4. Lupus
6.5. Others

7. GLOBAL C REACTIVE PROTEIN (CRP) TESTING MARKET FORECAST BY END USERS

7.1. Hospitals and Clinics
7.2. Diagnostic Centres

8. GLOBAL C REACTIVE PROTEIN (CRP) TESTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)

8.1. North America
  8.1.1. The U.S
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. U.K.
  8.3.2. France
  8.3.3. Germany
  8.3.4. Italy
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. UAE
  8.4.3. Israel
  8.4.4. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. India
  8.5.3. Australia
  8.5.4. South Korea
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. COMPANY PROFILES

10.1. Medixbiochemica
  10.1.1. Overview
  10.1.2. Financials
  10.1.3. Product and Services
  10.1.4. Recent Developments
10.2. Abbott
  10.2.1. Overview
  10.2.2. Financials
  10.2.3. Product and Services
  10.2.4. Recent Developments
10.3. Novus Biologicals, LLC
  10.3.1. Overview
  10.3.2. Financials
  10.3.3. Product and Services
  10.3.4. Recent Developments
10.4. Cenogenics Corporation
  10.4.1. Overview
  10.4.2. Financials
  10.4.3. Product and Services
  10.4.4. Recent Developments
10.5. Siemens Healthcare Private Limited
  10.5.1. Overview
  10.5.2. Financials
  10.5.3. Product and Services
  10.5.4. Recent Developments
10.6. Salimetrics, LLC
  10.6.1. Overview
  10.6.2. Financials
  10.6.3. Product and Services
  10.6.4. Recent Developments
10.7. Randox Laboratories Ltd.
  10.7.1. Overview
  10.7.2. Financials
  10.7.3. Product and Services
  10.7.4. Recent Developments
10.8. Thermo Fisher Scientific
  10.8.1. Overview
  10.8.2. Financials
  10.8.3. Product and Services
  10.8.4. Recent Developments
10.9. Beckman Coulter, Inc.
  10.9.1. Overview
  10.9.2. Financials
  10.9.3. Product and Services
  10.9.4. Recent Developments
10.10. Trinity Biotech
  10.10.1. Overview
  10.10.2. Financials
  10.10.3. Product and Services
  10.10.4. Recent Developments